Williams Jones Wealth Management, LLC. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 88 filers reported holding ONCOCYTE CORP in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Williams Jones Wealth Management, LLC. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q1 2023$5,316
+10.4%
15,0000.0%0.00%
Q4 2022$4,814
-56.2%
15,0000.0%0.00%
Q3 2022$11,000
-15.4%
15,0000.0%0.00%
Q2 2022$13,000
-40.9%
15,0000.0%0.00%
Q1 2022$22,000
-33.3%
15,0000.0%0.00%
Q4 2021$33,000
-57.7%
15,0000.0%0.00%
-100.0%
Q1 2021$78,000
+116.7%
15,0000.0%0.00%0.0%
Q4 2020$36,000
+71.4%
15,0000.0%0.00%
Q3 2020$21,000
-27.6%
15,0000.0%0.00%
-100.0%
Q2 2020$29,000
-21.6%
15,0000.0%0.00%0.0%
Q1 2020$37,000
+8.8%
15,0000.0%0.00%0.0%
Q4 2019$34,000
+6.2%
15,0000.0%0.00%0.0%
Q3 2019$32,00015,0000.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders